General Prescribing Guidance
LLR Prescribing
Anticholinergic side-effects and prescribing guidance
BMA statement regarding Cancard
Fixed dose Combination tablets -position statement
Guidance on Generic SGLT2i Prescribing in LLR
Haloperidol 0.5mg Tablets Review Process
Homeopathic Medicines – LMSG Statement
Hydroxycarbamide Prescribing Update and Retirement of Shared Care Agreement (SCA)
LLR ICB Position Statement Subcutaneous injection of Low Molecular Weight Heparin in Primary Care
LLR Standards for Prescribing in Primary Care
LLR Standards for Prescribing across the NHS-Private interface
LLR Standards for Prescribing and Medicines Management at the Interface
LLR Guidance: Self care for Minor Ailments and Self Limiting Conditions
Over-the-Counter (OTC) Medicines: Patient FAQ for Self-Care
Opioid Prescribing Guide For Non-Cancer Pain
Position Statement On The Safe Supply of Methotrexate Tablets
Preparing to use denosumab 60mg biosimilar
Preparing to use denosumab 120mg biosimilar
Recording Medicines Prescribed and Issued by Other Healthcare Providers
Look Alike Sound Alike (LASA) resources
Look Alike Sound Alike (LASA) Items
Look Alike Sound Alike A-Listers
Minimising the risk of Look-Alike Sound-Alike medication errors
Prescribing in Pregnancy
Best Use of Medicines in Pregnancy Patient Leaflets
Transferring Care Safely
Transferring Care Safely Interface Guidance
Transferring Care Safety: Response Timescales and Indicative (Agile) Criteria
Excipients
Common Excipients Which May Cause Adverse Effects in Children
EMA Annex for Labelling of Excipients
Gender Dysphoria
Gender Dysphoria Guide to Helpful Links
Miscellaneous
Government guidance regarding prescribing for patients from abroad
UHL Patient Information Leaflets
NHSE free of charge (FOC) schemes national policy (Endorsed by LLR APC)